Medivation (MDVN - Get Report), Seattle Genetics (SGEN - Get Report) and BioMarin (BMRN - Get Report): A wave of biotech acquisitions could be coming, said Cramer, and these three companies are prime takeover targets.
To read a full recap of "Mad Money" on CNBC, click here.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC